Compare · DHAC vs HIMS
DHAC vs HIMS
Side-by-side comparison of Digital Health Acquisition Corp. (DHAC) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHAC and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.51B, about 43.9x DHAC ($148.1M).
- HIMS has hit the wire 20 times in the past 4 weeks while DHAC has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 0 for DHAC).
- Company
- Digital Health Acquisition Corp.
- Hims & Hers Health Inc.
- Price
- $13.11+8.76%
- $27.91-0.94%
- Market cap
- $148.1M
- $6.51B
- 1M return
- -
- -12.16%
- 1Y return
- -
- -41.58%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 0
- 20
- Recent ratings
- 0
- 25
Digital Health Acquisition Corp.
Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on technology and healthcare focused businesses. The company was incorporated in 2021 and is based in Boca Raton, Florida.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest DHAC
- SEC Form 4 filed by Large owner Digital Health Sponsor Llc
- SEC Form 4 filed by Large owner Sands Lawrence M.
- Co-CEO Chen Milton acquired 2,870,069 shares (SEC Form 4)
- Co-CEO Aisiku Imoigele acquired 3,536,990 shares (SEC Form 4)
- New insider Sands Lawrence M. claimed ownership of 500,000 shares (SEC Form 3)
- SEC Form 3 filed by new insider Chen Milton
- SEC Form 3 filed by new insider O'Sullivan Colin P.
- SEC Form 3 filed by new insider Aisiku Imoigele
- SEC Form 3 filed by new insider Leonard Jerry
- SEC Form 25-NSE filed by Digital Health Acquisition Corp.
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
- Hims Arrives in Australia, Bringing Personalised Care for Men Nationwide
- Berger Montague PC Investigates Hims & Hers Health, Inc.’s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)
- Chief Executive Officer Dudum Andrew gifted 463,289 shares and disposed of 977,566 shares (SEC Form 4)
- Chief Policy Officer Autor Deborah M. sold $467,128 worth of shares (16,773 units at $27.85) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 48,961 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi sold $148,111 worth of shares (4,938 units at $29.99) as part of a pre-agreed trading plan and exercised 4,938 shares at a strike of $5.01 (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $691,808 worth of shares (25,111 units at $27.55) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 313,964 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 339,075 units (SEC Form 4) to satisfy tax liability
- Chief Medical Officer Carroll Patrick Harrison converted options into 26,187 shares and covered exercise/tax liability with 10,201 shares, increasing direct ownership by 9% to 197,847 units (SEC Form 4) (for tax liability)